SYNCORP educational trust (www.syncorp.org) is associated with the University of Mysore, offers Master Degree in Clinical Research, other Diploma Courses, PG Graduate Programs, and Professional skill development programs. A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN) (BrigHTN). Available from: https://www.clinicaltrials.gov/ct2/show/NCT04519658?term=cin-107&draw=2&rank=2 [Last accessed 28 Dec 2022] The Prestige (2006)". Box Office Mojo. Archived from the original on 21 June 2009 . Retrieved 3 January 2013.

Previously, Deepak held the position of Vice President, Global Data Services, and General Manager India while working at Syneos Health (previously inVentiv Health Clinical), occupied this position for 5.5 Years. Associate Vice President & Solutions Head, Life Sciences HLS LOB, while working at Wipro BPO Solutions Limited, held this role for 1.5 Years. Director Operations & Customer Leader, Life Sciences and Healthcare, while working at Tata Consultancy Services Limited, he occupied this position for 2 years. Dy. General Manager & Head ¬ Clinical Data Management, while working at Reliance Industries Limited, held this role for 4 years. Head Executive Central Laboratory and QA, while working at Clinigene International, A Biocon company, held this role for 6.5 years. Application Manager Cadila Pharmaceutical diagnostics and Analytical division held this role for 4 years. Medical Writing at Syncorp Health includes Regulatory, Marketing, Clinical writing services including publications. The team has expertise in developing documents in accordance to the SOPs and customized per sponsor’s requirements that comply to ICH GCP guidelines. Strong team with International and Indian regulatory experience in writing regulatory documents for USFDA, EMA and DCGI submissions Besieged on all sides, SynCorp’s Five Factions are in retreat. The rebels aim to destroy the Company to free mankind. But does mankind really want to be freed? Cliantha Research, full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Tobacco Research, Dermatology, Consumer Research, Research, Lab services, IVRT, Biometrics, Medical Services, Environmental Exposure Chambers (EECs).Cliantha, by leveraging on the depth of experience provides ethical, value added customer centric services rooted in excellence, thereby enabling clinical development of pharmaceutical, biotech & healthcare companies. Dr. Arvind has authored several medical books and published articles in premier International medical journals such as Lancet, GUT and Gastroentology. He has also been a medical teacher and examiner both in India and the United Kingdom. CinCor holds the exclusive, worldwide licence to baxdrostat, which will remain in place following the transaction. Rubin, Rebecca (10 December 2020). "After Christopher Nolan's Explosive Remarks, Could Warner Bros. Lose Its Superstar Director?". Variety. Archived from the original on 11 December 2020 . Retrieved 11 December 2020.

Our team and consultants have decade plus year of experience in clinical research, consulting, and services sector The Dark Knight (2008)". Box Office Mojo. Archived from the original on 2 January 2010 . Retrieved 3 January 2013. Board Member and President Syncorp Health, he brings over thirty (30) plus years of experience in Life Sciences & Health Care (LSHC) industry. Led the businesses in Strategic roles in companies like TCS LSHC, Wipro LSHC, Reliance, Biocon Ltd, Syneos Health & Cadila Pharmaceutical, experiences includes P&L leadership, building Offshoring, go-to-market strategies & Solutioning, Transitions, Transformation initiatives, & Quality Management services in Contract Research Organizations (CRO), BPO Life Sciences & Health Care (LSHC).CinCor Pharma Announces Topline Data for Phase 2 HALO Trial Evaluating Selective Aldosterone Synthase Inhibitor Baxdrostat in Uncontrolled Hypertension. Available from: https://www.cincor.com/news-releases/news-release-details/cincor-pharma-announces-topline-data-phase-2-halo-trial [Last accessed 30 Dec 2022].